SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-238896
Filing Date
2022-09-06
Accepted
2022-09-06 16:33:08
Documents
11

Document Format Files

Seq Description Document Type Size
1 425 d365622d425.htm 425 559468
2 GRAPHIC g336866dsp90.jpg GRAPHIC 5183
3 GRAPHIC g336866ex99_2s1g1.jpg GRAPHIC 371939
4 GRAPHIC g336866ex99_2s2g1.jpg GRAPHIC 865656
5 GRAPHIC g336866ex99_2s3g1.jpg GRAPHIC 594959
6 GRAPHIC g336866ex99_2s4g1.jpg GRAPHIC 423671
7 GRAPHIC g336866ex99_2s5g1.jpg GRAPHIC 387996
8 GRAPHIC g336866ex99_2s6g1.jpg GRAPHIC 224362
9 GRAPHIC g336866ex99_2s7g1.jpg GRAPHIC 402934
10 GRAPHIC g336866ex99_2s8g1.jpg GRAPHIC 330355
11 GRAPHIC g336866ex99_2s9g1.jpg GRAPHIC 327970
  Complete submission text file 0001193125-22-238896.txt   5982310
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filed by) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Subject) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39512 | Film No.: 221228663
SIC: 2834 Pharmaceutical Preparations